Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

G. Contant, Theodore E. Spiro, Elisabeth Perzborn, +6

Thrombosis and Haemostasis

Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions

M. Atger, Micheline Misrahi, Sokhavuth Sar, +3

Molecular and Cellular Endocrinology

Molecular PhysiologyNatural SciencesGeneticsHormonal ReceptorReceptor (Biochemistry) +9

Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls

M Samama, G. Contant, Theodore E. Spiro, +5

Clinical and Applied Thrombosis/Hemostasis

Local Pt ReagentsMeasurementEducationThrombosisBioanalysis +15

Mutations in Promoter Region of Thrombomodulin and Venous Thromboembolic Disease

Léna Le Flem, Véronique Picard, Joseph Emmerich, +4

Arteriosclerosis Thrombosis and Vascular Biology

In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux

M Samama, Jeanne Mendell, Céline Guinet, +2

Thrombosis Research

Thrombin GenerationThrombosisVenous ThrombosisBlood PlateletMedicine +11

Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins

Léna Le Flem, Louise Mennen, Marie-Laurence Aubry, +4

Arteriosclerosis Thrombosis and Vascular Biology

VaricesThrombosisVal MutationVenous DiseaseVenous Thrombosis +13

Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study

M Samama, Céline Guinet, Léna Le Flem, +2

Journal of Thrombosis and Thrombolysis

ThrombosisPulmonary EmbolismPrimary PreventionVenous ThrombosisCardiovascular Disease +10

Do new oral anticoagulants require laboratory monitoring? The clinician point of view

M Samama, Céline Guinet, Léna Le Flem

Thrombosis Research

ThrombosisTherapeutic Drug MonitoringVenous ThrombosisCardiovascular DiseaseLaboratory Monitoring +13

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study

Isabelle Gouin‐Thibault, Geneviève Freyburger, Emmanuel de Maistre, +39

Thrombosis Research

Apixaban Target-specific AssaysMulticenter French StudyTherapeutic Drug MonitoringPreclinical Drug EvaluationPharmacological Study +10